Balaxi Pharmaceuticals Limited (NSE:BALAXI)

Balaxi Pharmaceuticals Statistics

Total Valuation

NSE:BALAXI has a market cap or net worth of INR 2.39 billion. The enterprise value is 2.52 billion.

Market Cap	2.39B
Enterprise Value	2.52B

Important Dates

The next estimated earnings date is Tuesday, November 4, 2025.

Earnings Date	Nov 4, 2025
Ex-Dividend Date	n/a

Share Statistics

NSE:BALAXI has 55.21 million shares outstanding. The number of shares has increased by 5.04% in one year.

Current Share Class	55.21M
Shares Outstanding	55.21M
Shares Change (YoY)	+5.04%
Shares Change (QoQ)	-0.29%
Owned by Insiders (%)	4.55%
Owned by Institutions (%)	8.60%
Float	12.56M

Valuation Ratios

The trailing PE ratio is 12.66.

PE Ratio	12.66
Forward PE	n/a
PS Ratio	0.80
PB Ratio	1.03
P/TBV Ratio	1.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	13.33
EV / Sales	0.85
EV / EBITDA	8.06
EV / EBIT	8.56
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.23
Debt / EBITDA	1.71
Debt / FCF	n/a
Interest Coverage	8.24

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	7.27%
Return on Capital Employed (ROCE)	n/a
Revenue Per Employee	4.96M
Profits Per Employee	314,667
Employee Count	600
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, NSE:BALAXI has paid 33.18 million in taxes.

Income Tax	33.18M
Effective Tax Rate	14.95%

Stock Price Statistics

The stock price has decreased by -52.82% in the last 52 weeks. The beta is 0.59, so NSE:BALAXI's price volatility has been lower than the market average.

Beta (5Y)	0.59
52-Week Price Change	-52.82%
50-Day Moving Average	45.10
200-Day Moving Average	55.27
Relative Strength Index (RSI)	46.25
Average Volume (20 Days)	56,951

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:BALAXI had revenue of INR 2.98 billion and earned 188.80 million in profits. Earnings per share was 3.42.

Revenue	2.98B
Gross Profit	1.30B
Operating Income	294.13M
Pretax Income	221.98M
Net Income	188.80M
EBITDA	310.26M
EBIT	294.13M
Earnings Per Share (EPS)	3.42

Balance Sheet

The company has 407.03 million in cash and 534.25 million in debt, giving a net cash position of -127.22 million or -2.30 per share.

Cash & Cash Equivalents	407.03M
Total Debt	534.25M
Net Cash	-127.22M
Net Cash Per Share	-2.30
Equity (Book Value)	2.32B
Book Value Per Share	41.98
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 43.78%, with operating and profit margins of 9.88% and 6.34%.

Gross Margin	43.78%
Operating Margin	9.88%
Pretax Margin	7.46%
Profit Margin	6.34%
EBITDA Margin	10.42%
EBIT Margin	9.88%
FCF Margin	n/a

Dividends & Yields

NSE:BALAXI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.04%
Shareholder Yield	-5.04%
Earnings Yield	7.90%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on May 30, 2024. It was a forward split with a ratio of 5.

Last Split Date	May 30, 2024
Split Type	Forward
Split Ratio	5

Scores

Altman Z-Score	n/a
Piotroski F-Score	1